Tofflon has four core divisions: Biotechnology Division, Preparation Equipment Division, Engineering Division and Food Engineering Division. It can provide process equipment, core consumables and technical support for different processes and dosage forms in the development and production of small molecular drugs, macromolecular biological drugs, CGT drugs and APIs. Provide consulting, design, construction, verification, informationization, public works and other services for pharmaceutical plants in the field of pharmaceutical engineering. In the food field, we provide equipment and turnkey engineering services including process technology research and development, engineering design, equipment manufacturing, engineering installation and training services for dairy products, beverages, alcoholic beverages, health products and food additives.
Tofflon is a total solution service provider supplying process services and consumables, core equipment, and engineering for global pharmaceutical companies.
Tofflon continues to strengthen the research of pharmaceutical manufacturing science and pharmaceutical machinery manufacturing science, and strives to build a "next-generation pharmaceutical manufacturing platform" to provide professional solutions for customers in R&D, pilot and commercial production, and help the rapid development and large-scale commercial production of drugs.
We have experienced engineers, technical support and after-sales team to speed up the development and production process of more efficient and affordable drugs, benefiting doctors and patients.
Persist in technological innovation
Tofflon brings together global technologies to serve the pharmaceutical industry. We have built advanced experimental platforms for pharmaceutical research, biotechnology, complex preparations and solid preparations, and are committed to building the most advanced pharmaceutical manufacturing platform.
Sustainable Development
We practice the business strategy of sustainable development, use some clean energy instead of traditional energy, and continue to develop green pharmaceutical equipment and facilities with low energy consumption and environmental protection to help the industry achieve the goal of "double carbon"